NCT03050112 is a NA clinical trial of MacNew questionnaire in Congenital Heart Disease, sponsored by Pierre Wauthy.

Who is sponsoring NCT03050112?

NCT03050112 is sponsored by Pierre Wauthy.

What drugs are being tested in NCT03050112?

Interventions in NCT03050112: MacNew questionnaire.

What condition does NCT03050112 study?

NCT03050112 studies Congenital Heart Disease.

Is NCT03050112 still recruiting?

NCT03050112 is currently completed. Last updated 22 November 2017.

Last reviewed 2017-11-22 · How we verify

NCT03050112

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long-term Quality of Life of Patients With a Congenital Heart Disease, Treated by Surgery in Adulthood at the Brugmann Hospital.

Completed NA Last updated 22 November 2017

What this trial tests

NA trial testing MacNew questionnaire in Congenital Heart Disease in 250 participants. Completed in 1 June 2017.

Timeline

14 February 2017

Primary endpoint
1 June 2017

1 June 2017

Quick facts

Lead sponsor	Pierre Wauthy
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	250
Start date	14 February 2017
Primary completion	1 June 2017
Estimated completion	1 June 2017
Sites	1 location across Belgium

Drugs / interventions tested

MacNew questionnaire

Conditions studied

Congenital Heart Disease — all drugs for Congenital Heart Disease →

Sponsor

Pierre Wauthy

Who can join

16 and older, any sex, with Congenital Heart Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Adults with a congenital heart disease, having undergone a surgical intervention or a re-do surgery in adulthood, are a growing group of subjects in the general population. This increase is explained by improved medical and surgical techniques, with a better survival rate as outcome. There is nowadays a growing interest in the quality of life of this group of subjects. However, studies give contradictory results. This can be explained on one hand by the vast majority of pathologies within this population, and on the other hand by the absence of a cardio-specific tool for quality of life measurement. The MacNew questionnaire is cardio-specific. It allows an evaluation of the quality of life based on the exploration of three domains: physical, emotional and social. The aim of this study is: * to evaluate the quality of life of these patients, by using the MacNew questionnaire * to explore the needs in terms of prevention, treatment and multi-disciplinary follow-up * to assess the mortality within this group of patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Congenital Heart Disease

Currently open trials in the same condition.

NCT07193719 — Influence of Personalized Lung Volume Optimization Maneuver on Lung Function and Cardiac Performance in Children · Phase 1, PHASE2 · recruiting
NCT07023367 — Parent Navigator Program (PNP) to Improve Outcomes in Latino/x Children and Parents · NA · recruiting
NCT06833320 — Propranolol Treatment for Postoperative Chylothorax · Phase 1, PHASE2 · recruiting
NCT06668389 — Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary · Phase 4 · recruiting
NCT06872320 — The Influence of Probiotics on Metabolome and Heart Rate Variability in Heart Failure of Structure Heart Disease · NA · active not recruiting

Other Pierre Wauthy trials

Trials by the same sponsor.

NCT03922191 — Post-Surgical Mediastinitis Within the CHU Brugmann Hospital · completed
NCT03922178 — Evaluation of Hemodynamic Changes of the Left Ventricle Following the Use of Extracorporeal Circulation · NA · completed
NCT03917706 — Development of a Quality of Life Assessment Tool for Adult Patients With a Congenital Heart Disease, Having Had Surgery · completed
NCT03402542 — Eligibility Criteria for Cholecystectomy in Ambulatory Surgery · completed
NCT03083301 — Cardiac Resynchronization Therapy: Relevance of the Surgical Approach in the Implantation of the Left Ventricular Probe · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03050112 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pierre Wauthy
Last refreshed: 22 November 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03050112.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing